Margolin Jacob 4
4 · Clinigence Holdings, Inc. · Filed Sep 29, 2020
Insider Transaction Report
Form 4
Margolin Jacob
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2020-07-13$179800.00/sh+228,346$41,056,610,800→ 574,998 total - Purchase
Common Stock
2020-06-30$45000.00/sh+31,034$1,396,530,000→ 349,652 total - Award
Director Stock Option (right to buy)
2020-05-11+30,000→ 30,000 totalExercise: $1.50From: 2020-05-11Exp: 2027-05-11→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1](1) Does not include 30,000 options reported on Table II.